NovaBay Pharmaceuticals Regains Compliance With NYSE American Listing Standards
I'm PortAI, I can summarize articles.
NovaBay Pharmaceuticals Inc. has regained compliance with NYSE American listing standards after addressing deficiencies in stockholders’ equity. The company raised approximately $8.15 million through the sale of pre-funded warrants and Series E non-voting convertible preferred stock, increasing its stockholders’ equity above the required $6 million threshold. The NYSE American has confirmed that all related deficiencies have been resolved.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments